Replies to post #3191 on Galectin Therapeutics Inc. (GALT)

[Amatuer17]

Company is maintaining the Dec 2017 deadline as of this week - see R&R deck. So we have clear binary event - it works or not.
If not significant downside

"Phase 2b clinical trial with potential registration endpoints fully enrolled with top line data readout in December 2017"

Slide 25 of the deck

http://galectintherapeutics.com/wp-content/uploads/2017/09/Galectin-Presentation-Updated_9.13.17.pdf